Bicycle Therapeutics Reports Recent Business Progress and Third Quarter 2023 Financial Results and Announces Upcoming R&D Day
CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)--Nov 2, 2023--Bicycle Therapeutics plc (NASDAQ: BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide ( <em>Bicycle ®</em> ) ...
